Keith Johnson

Harvard University — United States

Neuroscience · Life Sciences

46h-index12.3kcitations252works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Neurodegenerative Diseases(63), Mitochondrial Function and Pathology(26), Dementia and Cognitive Impairment Research(24), Neuroscience and Neuropharmacology Research(11), Genetics and Neurodevelopmental Disorders(11)

Publications252 total

S5105 CMV Colitis Presenting as Inflammatory Polyposis in a Patient With Common Variable Immunodeficiency
The American Journal of Gastroenterology·2025
Abstract 4244: Application of a membrane interactomics (MInt) platform for novel surface target discovery
Cancer Research·2025
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease
Alzheimer s Research & Therapy·2025· 4 citedOpen Access
Exon-Capture Data Resolve Relationships Resulting from a Rapid Radiation within Family Gobiidae
SSRN Electronic Journal·2025Open Access
Receptor-Interacting Protein Kinase-3 Expression Impacts Ocular Vascular Development and Pathological Neovascularization
Cells·2024Open Access
Diffusion-based Bayesian posterior distribution prediction of kinetic parameters in dynamic PET
2024
Effects of List-Mode-Based Intraframe Motion Correction in Dynamic Brain PET Imaging
IEEE Transactions on Radiation and Plasma Medical Sciences·2024· 2 citedOpen Access
<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease
New England Journal of Medicine·2024· 47 citedOpen Access
Congenital and Developmental Disorders
Medical radiology·2024
Trial of Solanezumab in Preclinical Alzheimer’s Disease
New England Journal of Medicine·2023· 322 citedOpen Access
Impact of motion correction on [<sup>18</sup>F]-MK6240 tau PET imaging
Physics in Medicine and Biology·2023· 9 citedOpen Access
Novel <i>CYP1B1-RMDN2</i> Alzheimer’s disease locus identified by genome-wide association analysis of cerebral tau deposition on PET
2023· 5 citedOpen Access
High-Resolution Structural Brainstem Nuclei: Locus Coeruleus Integrity as Potential Biomarker of Alzheimer’s Disease-Related Phenotypes
Biological Psychiatry·2022· 1 cited
Conquering The Hurdles Of The Tenure And Promotion Process For The Junior Faculty Members
2020
Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients
Network and Systems Medicine·2020· 42 citedOpen Access
The effect of pulsatile pump perfusion on hepatitis C transmission in kidney transplantation: A prospective pilot study
Clinical Transplantation·2020· 2 cited
Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders
Clinical Rheumatology·2019· 62 citedOpen Access
Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred
The Journal of Prevention of Alzheimer s Disease·2019· 58 citedOpen Access
Anti-KIR Antibodies Treat Lupus in Mice
2019
[IC‐P‐089]: ANXIETY, SUBJECTIVE COGNITIVE DECLINE, AND CORTICAL AMYLOID IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER's DISEASE: A PRELIMINARY REPORT
Alzheimer s & Dementia·2017
page 1 of 13Next →

Frequent Co-authors

Peggy Shelbourne(8), June Davies(7), Jessica L. Buxton(7), Maria Anvret(5), Nessa Carey(5), Brien P. Riley(3), Reisa A. Sperling(3), Catherine Boucher(3), Michael J. Siciliano(3), Ward Pa(3), H G Harley(2), S.A. Rundle(2), Clare Jones(2), Vesa Juvonen(2), Charalampos Aslanidis(2), Gert Jansen(2), Robert Williamson(2), Thomas Deufel(2), Christian Lavedan(2), Jean‐Pierre Rabès(2)